Vivani Medical is trading at $1.43 (+5.54%) after no clear company-specific catalyst was identified for September 9, 2026.

  • The latest company announcement concerns investor conferences scheduled for September 10 and September 14–16, not a September 9 development.
  • Broader U.S. pre-market sentiment is weaker, so the gain appears unexplained rather than market-driven.